Jan Garfinkle - Profile and Investment Details

Investor Profile

Jan Garfinkle is a Venture Capital, Private Equity Firm, Investor based in Detroit, Michigan, United States with a diverse investment portfolio that includes companies such as Strata Oncology, Koya Medical, RareCyte, AtaCor Medical, Inc., NeuMoDx Molecular, Inc., Devices for Vascular Intervention/Guidant, NxThera, Trinity Health System - Michigan Region, National Venture Capital Association, Francis Medical, HandyLab, Inc., Koya Medical, Inc., Flosonics, nVision Medical, Uptake Medical, BAROnova, Reprieve Cardiovascular, Esperion Therapeutics, Ann Arbor, MI, CardioMEMS, RareCyte, Inc., Bank of Ann Arbor, . Over time, Jan Garfinkle has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jan Garfinkle is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Wellness, Women Founded, Life Science, Portfolio Management, Analytics, Software, Biotechnology, Medical Devices, Electronic Health Records (EHR), Clinical Trials, Consumer Internet, Digital Health, Medical, SaaS, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Media and Entertainment, Diverse Founder Investments, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Jan Garfinkle, as their portfolio suggests a familiarity and interest in this area.

Understanding Jan Garfinkle’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.